Sponsorship, Authorship, and Accountability
- 13 September 2001
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 345 (11), 825-827
- https://doi.org/10.1056/nejmed010093
Abstract
As editors of general medical journals, we recognize that the publication of clinical-research findings in respected peer-reviewed journals is the ultimate basis for most treatment decisions. Public discourse about this published evidence of efficacy and safety rests on the assumption that clinical-trials data have been gathered and are presented in an objective and dispassionate manner. This discourse is vital to the scientific practice of medicine because it shapes treatment decisions made by physicians and drives public and private health care policy. We are concerned that the current intellectual environment in which some clinical research is conceived, study subjects are recruited, and the data are analyzed and reported (or not reported) may threaten this precious objectivity.Keywords
This publication has 3 references indexed in Scilit:
- Evaluation of HIV-1 Immunogen, an Immunologic Modifier, Administered to Patients Infected With HIV Having 300 to 549 × 106/L CD4 Cell CountsA Randomized Controlled TrialPublished by American Medical Association (AMA) ,2000
- Thyroid stormPublished by American Medical Association (AMA) ,1997
- Withholding research results in academic life science. Evidence from a national survey of facultyPublished by American Medical Association (AMA) ,1997